source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
The Motley Fool | 2023-02-04 08:30:00 | https://www.fool.com/investing/2023/02/04/2-stocks-down-more-than-6-to-buy-right-now/ | These companies outperformed the market last year. | 2 Stocks Down More Than 6% to Buy Right Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-02-04 07:45:00 | https://www.fool.com/investing/2023/02/04/3-unstoppable-dividend-stocks-to-buy-in-february/ | All three belong to the elite group of stocks known as Dividend Kings. | 3 Unstoppable Dividend Stocks to Buy in February | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2023-02-03 22:53:10 | https://247wallst.com/investing/2023/02/03/5-best-and-worst-performing-mega-cap-stocks-in-january-2023/ | The stock market finished January on a positive note. This is a good sign for investors, who incurred huge losses last year. | 5 Best and Worst Performing Mega-Cap Stocks in January 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-03 10:32:34 | https://www.zacks.com/stock/news/2049505/investors-heavily-search-abbvie-inc-abbv-here-is-what-you-need-to-know | Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. | Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-02-03 10:07:00 | https://www.fool.com/investing/2023/02/03/if-you-want-passive-income-buy-these-two-stocks/ | Good cash flows come to those who pick intelligently and wait. | If You Want Tons of Passive Income in the Future , Buy These 2 Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-02-03 07:00:13 | https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-manager-found-a-way-to-make-money-while-others-lose/ | Making money in an up market is easy. But showering investors with gains when stocks fall is far more challenging for the best mutual funds. | Top Fund Manager Found A Way To Make Money While Others Lose | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-02-01 05:55:00 | https://www.fool.com/investing/2023/02/01/juicy-dividend-stocks-warren-buffett-buy-february/ | These stocks aren't in Berkshire Hathaway's SEC filings, but Buffett owns them. | 3 Juicy Dividend Stocks in Warren Buffett's Secret Portfolio to Buy in February | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
24/7 Wall Street | 2023-01-31 22:55:59 | https://247wallst.com/investing/2023/01/31/10-biggest-companies-reporting-earnings-in-the-second-week-of-feb-2023/ | The fourth quarter 2022 earnings season continues to be subpar for the S&P 500. | 10 Biggest Companies Reporting Earnings in the Second Week of Feb 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2023-01-31 12:21:13 | https://www.gurufocus.com/news/1939635/5-dividend-king-stocks-gurus-are-feasting-on | According to the All-in-one Screener, a Premium feature of GuruFocus, five dividend kings stocks that have high guru ownership as of the third-quarter 2022 13F portfolio filings are Johnson & Johnson ( JNJ , Financial), Proctor & Gamble Co. ( PG , Financial), Coca-Cola Co. ( KO , Financial), AbbVie Inc. ( ABBV , Financ... | 5 Dividend King Stocks Gurus Are Feasting On | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-01-31 12:12:29 | https://www.investors.com/news/technology/abbvie-stock-the-20-year-humira-monopoly-ends-so-what-is-next/ | AbbVie's two-decade Humira monopoly came to an end Tuesday after Amgen launched its biosimilar copy. But AbbVie stock was mostly unmoved. | AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-29 05:42:31 | https://seekingalpha.com/article/4573349-abbvie-why-the-company-is-still-overvalued | According to the financial report of Johnson & Johnson, a partner of AbbVie, sales of Imbruvica decreased in the 4th quarter of 2022 due to increased competition. In less than six months, Humira's biosimilars will go on sale in the United States. | AbbVie: Why The Company Is Still Overvalued | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-01-28 13:12:08 | https://investorplace.com/2023/01/7-dividend-stocks-to-buy-now-or-youll-be-kicking-yourself-later/ | The recent rally in equities may be prying some cash off the sidelines. But if you're investing in pure growth stocks and avoiding dividend stocks altogether, I'd urge caution. | 7 Dividend Stocks to Buy Now or You'll Be Kicking Yourself Later | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-28 09:00:00 | https://seekingalpha.com/article/4572580-the-4-percent-dgi-core-portfolio-2022-year-end-review | We present the 2022 year-end review of our eight-year-old Passive DGI-Core Portfolio. We consider this portfolio and strategy as the foundation of our overall portfolio. We will provide updates on changes, additional investments, dividends collected, and an overall 2022 performance. | The 4% DGI Core Portfolio: 2022 Year-End Review | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2023-01-27 15:19:19 | https://www.youtube.com/watch?v=stmqiE_fNAQ | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: Abbvie, S&P Global and more | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-27 15:13:01 | https://seekingalpha.com/article/4573086-february-dividend-kings-5-buys-1-to-watch | "There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the Dow. The 47 Dividend Kings screened as of January 25, 2023, represented eight of eleven Morningstar Sectors. Broker tar... | February Dividend Kings: 5 Buys; 1 To Watch | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-01-25 17:20:18 | https://investorplace.com/2023/01/3-gene-editing-stocks-to-buy-now-or-youll-be-kicking-yourself-later/ | To many investors, gene editing sounds like the plot of a science fiction movie. The concept of being able to edit our DNA to cure genetic diseases is quite unbelievable, and the upside of gene editing to treat rare diseases is impressive. | 3 Gene Editing Stocks to Buy Now OR You'll Be Kicking Yourself Later | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-25 07:05:00 | https://www.fool.com/investing/2023/01/25/3-reasons-to-buy-abbvie-and-2-reasons-not-to-buy/ | The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition. | 3 Reasons to Buy AbbVie and 2 Reasons Not to Buy | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-25 06:00:00 | https://www.fool.com/investing/2023/01/25/want-safety-growth-in-2023-try-dividend-stocks/ | Passive income is particularly welcome during tough market times. | Want Safety and Growth in 2023? Try These Dividend Stocks. | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-24 09:15:00 | https://seekingalpha.com/article/4571809-dividend-kings-ranked-by-quality-score | Dividend Kings have an astounding track record of 50 or more years of higher dividend payouts. I rank the Dividend Kings using Quality Snapshots, a simple yet elegant system for assessing the quality of dividend growth stocks. | The Dividend Kings Ranked By Quality Score | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-24 08:00:00 | https://seekingalpha.com/article/4571732-3-irresistible-dividend-kings | I'm starting this article with a theoretical background explaining the benefits that come with high-quality dividends. We dive into empirical evidence supporting a wide variety of dividend strategies. The theme of this article is dividend kings, which are stocks that have hiked their dividends for at least 50 consecuti... | 3 Irresistible Dividend Kings | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-23 22:16:42 | https://seekingalpha.com/article/4571791-selecting-dividend-aristocrats-using-schd-methodology-slow-steady | I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD. | Selecting Dividend Aristocrats Using SCHD Methodology - Slow And Steady | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-23 10:32:28 | https://www.zacks.com/stock/news/2042605/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know | AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. | AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-22 22:53:21 | https://seekingalpha.com/article/4571519-ranking-the-diversified-healthcare-giants | The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles. | Ranking The Diversified Healthcare Giants | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-22 19:05:00 | https://www.fool.com/investing/2023/01/22/2-top-passive-income-stocks-to-own-in-2023/ | These dividend stocks can deliver both downside protection and capital appreciation. | 2 Top Passive-Income Stocks to Own in 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-22 05:30:00 | https://www.fool.com/investing/2023/01/22/abbvie-to-lose-on-blockbuster-but-can-still-grow/ | Two newer immunology drugs look like big tickets to growth. | AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry. | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2023-01-20 15:56:08 | https://www.youtube.com/watch?v=FEa4tlfm1Mo | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: Abbvie, Goldman Sachs, Charles River & more | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-20 14:14:58 | https://seekingalpha.com/article/4571271-better-2023-dividend-stock-abbvie-or-johnson-and-johnson | My main thesis is to explain why AbbVie Inc. remains my top 2023 dividend stock in the healthcare space despite its near-record stock prices. The thesis is best illustrated by comparison and contrast against another dividend champ, Johnson & Johnson. | Better 2023 Dividend Stock: AbbVie Or Johnson & Johnson? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-01-20 11:55:22 | https://investorplace.com/2023/01/7-stocks-every-smart-investor-should-own-in-2023/ | At the rate things are going, a recession is likely. All thanks to the Federal Reserve, which once tried — laughably — to convince us inflation was transitory. | 7 Stocks Every Smart Investor Should Own in 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-01-18 15:44:49 | https://investorplace.com/2023/01/7-biotech-stocks-that-will-make-you-rich-in-10-years/ | If you have the patience to go through wild undulations, then you may be a candidate for biotech stocks that will make you rich in 10 years. Even among the most established biotechnology firms, they're seemingly one news item away from disaster. | 7 Biotech Stocks That Will Make You Rich in 10 Years | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-18 11:35:41 | https://seekingalpha.com/article/4570639-blue-chip-stocks-red-flags-due-diligence | Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan? Potentially devastating litigation? Overlooked liabilities on the balance sheet? Financial engineering? | Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-17 20:05:57 | https://seekingalpha.com/article/4570462-abbvie-abbv-stock-to-buy-not-to-buy | AbbVie is a quality BBB+ S&P credit rated healthcare stock with a 3.9% yield. It has 11 years of a rising dividend and an amazing 5-year dividend growth rate of 17.7%. | AbbVie : To Buy Or Not To Buy | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-17 10:07:00 | https://www.fool.com/investing/2023/01/17/could-this-fda-approval-boost-abbvies-stock/ | Last month, one of its anti-psychotic drugs received approval from the Food and Drug Administration for another indication. | Could This FDA Approval Boost AbbVie's Stock? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-17 07:45:00 | https://www.fool.com/investing/2023/01/17/with-competition-on-rise-is-abbvie-dividend-safe/ | This year isn't starting on the best of notes for the drugmaker. | With Competition on the Rise, Is AbbVie's Dividend Safe? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-17 05:47:00 | https://www.fool.com/investing/2023/01/17/is-abbvie-a-good-dividend-stock-to-buy-on-the-dip/ | The stock offers an attractive yield, but investors need to brace for declining revenue this year. | Is AbbVie a Good Dividend Stock to Buy on the Dip? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-16 08:45:00 | https://www.fool.com/investing/2023/01/16/5-dividend-kings-i-bought-for-my-portfolio/ | Rely upon income-generating stocks to see your portfolio through times of upheaval. | 5 Dividend Kings I Bought for My Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-12 09:30:00 | https://seekingalpha.com/article/4569282-my-six-figure-market-beating-dividend-growth-portfolio | As requested by many, I decided to dedicate an article to my personal dividend growth portfolio, consisting of more than 90% of my net worth. I start by explaining my strategy and approach, followed by a discussion of the benefits that come with dividend (growth) investment strategies. | My 6-Figure Market-Beating Dividend Growth Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-11 14:40:54 | https://seekingalpha.com/article/4569297-4-factor-dividend-growth-portfolio-december-2022-results | The 4 factor dividend growth portfolio was launched on November 1st, 2022, and is thus far off to a great start. The portfolio generated 0.28% of alpha in December and continues to outpace the S&P 500 Total Return. | 4 Factor Dividend Growth Portfolio - December 2022 Results | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-11 12:34:48 | https://seekingalpha.com/article/4569273-ranking-the-10-largest-biotechs-by-pipeline | The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment insights. | Ranking The 10 Largest Biotechs By Pipeline | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-11 07:50:00 | https://www.fool.com/investing/2023/01/11/3-supercharged-dividend-stocks-to-buy-if-theres-a/ | These three healthcare stocks all deliver dependable dividends, with yields of 3% or more. | 3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-11 07:10:00 | https://www.fool.com/investing/2023/01/11/if-you-like-dividends-you-should-love-these-3-stoc/ | From growth to value, these companies reward shareholders handsomely. | If You Like Dividends, You Should Love These 3 Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-11 05:30:00 | https://www.fool.com/investing/2023/01/11/1-hot-growth-stock-to-buy-now-and-1-to-avoid/ | One company is gearing up for further growth while the other stumbles over itself. | 1 Hot Growth Stock to Buy Now, and 1 to Avoid | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-10 20:04:08 | https://seekingalpha.com/article/4569123-abbvie-inc-abbv-41st-annual-j-p-morgan-healthcare-conference-transcript | AbbVie Inc. (NYSE:ABBV ) 41st Annual J.P. Morgan Healthcare Conference Call January 10, 2023 6:00 PM ET Company Participants Rick Gonzalez - Chairman and Chief Executive Officer Rob Michael - President Jeff Stewart - Chief Commercial Officer Conference Call Participants Chris Schott - J.P. | AbbVie Inc. (ABBV) 41st Annual J.P. Morgan Healthcare Conference - (Transcript) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-10 10:32:25 | https://www.zacks.com/stock/news/2037230/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know | Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store. | AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-10 05:31:00 | https://www.fool.com/investing/2023/01/10/should-investors-worry-about-abbvie-dividend/ | The risks are real, but they're decreasing over time. | Should Investors Worry About AbbVie's Dividend? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-09 23:44:41 | https://seekingalpha.com/article/4568885-ranking-the-top-10-pharmaceuticals-by-pipeline | The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance. | Ranking The Top 10 Pharmaceuticals By Pipeline | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-01-09 12:48:00 | https://www.marketwatch.com/story/these-15-dividend-aristocrat-stocks-have-been-the-best-income-builders-11673286478 | The S&P Dividend Aristocrats deserve more coverage. | These 15 Dividend Aristocrat stocks have been the best income builders | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Stockmarketcom | 2023-01-09 07:00:00 | https://stockmarket.com/featured/top-dividend-stocks-to-invest-in-2023-3-for-your-list-2023-01-09 | Do you have these top dividend stocks on your watchlist in 2023? | Top Dividend Stocks To Invest In 2023? 3 For Your List | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-01-08 13:30:38 | https://investorplace.com/best-dividend-stocks-for-grandkids/ | If you're looking for some of the best dividend stocks for grandkids, now is the time to buy. After all, 2022 was an absolute disaster. | The 7 Best Dividend Stocks to Buy for Your Grandkids in 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-08 00:02:13 | https://seekingalpha.com/article/4568491-dividend-champion-contender-and-challenger-highlights-week-of-january-8 | A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. | Dividend Champion, Contender, And Challenger Highlights: Week Of January 8 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Dog of Wall Street | 2023-01-07 11:30:00 | https://thedogofwallstreet.com/cost/2-blue-chip-stocks-to-buy-and-hold-forever?SNAPI | These stocks outperformed tech stocks in 2022 and are reliable investments in tough economic times. | 2 Blue Chip Stocks to Buy and Hold Forever | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-07 06:10:00 | https://www.fool.com/investing/2023/01/07/3-no-brainer-dividend-stocks-to-buy-in-2023/ | These stocks have what it takes to win over the long run. | 3 No-Brainer Dividend Stocks to Buy in 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Market Watch | 2023-01-06 18:44:00 | https://www.marketwatch.com/story/abbvie-cuts-earnings-forecast-due-to-milestone-payments-11673048665 | AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with the Securities and Exchange Commission late Friday, which cited research and development expenses and milestone payments to partners. | AbbVie cuts earnings forecast due to milestone payments | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-01-06 13:45:11 | https://www.investors.com/news/technology/abbvie-stock-briefly-breaks-out-on-a-new-cancer-deal/ | AbbVie stock briefly broke out Friday after the company signed a $30 million deal with small biotech Immunome in antibody development. The post AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal appeared first on Investor's Business Daily. | AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Dog of Wall Street | 2023-01-06 11:17:35 | https://thedogofwallstreet.com/abbv/abbvie-and-immunome-partner-to-find-new-cancer-treatments?SNAPI | Immunome and AbbVie announced a worldwide collaboration and option agreement to discover up to 10 new antibody-target pairs for treating three specific types of tumors using Immunome's technology. | AbbVie and Immunome Partner to Find New Cancer Treatments | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Schaeffers Research | 2023-01-06 08:00:00 | https://www.schaeffersresearch.com/content/analysis/2023/01/06/top-stock-picks-for-2023-abbvie | Every day for the next week, we're going to highlight one of Schaeffer's top seven picks for 2023. | Top Stock Picks for 2023: AbbVie | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-06 07:15:00 | https://seekingalpha.com/article/4567899-johnson-and-johnson-vs-abbvie-the-better-dividend-aristocrat-buy-might-shock-you | 2023 is likely to start out weak for stocks, and they could potentially fall 15% to 23% in the coming weeks. Healthcare is one of only two sectors that historically goes up in recessions, and dividend aristocrat healthcare is the most defensive of all. | Johnson & Johnson Vs. AbbVie: The Better Dividend Aristocrat Buy Might Shock You | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2023-01-05 13:58:22 | https://www.youtube.com/watch?v=tbZX9LWqJ-w | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: Abbvie, Goldman Sachs & more | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-05 13:36:24 | https://seekingalpha.com/article/4568075-8-upcoming-dividend-increases-dividend-king | All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 7.4% and a median increase of 6.1%. | 8 Upcoming Dividend Increases, Including A Dividend King | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2023-01-05 08:00:00 | https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-2022-earnings-conference-call-301711231.html | NORTH CHICAGO, Ill. , Jan. 5, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens. | AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-01-04 08:05:52 | https://www.investors.com/research/breakout-stocks-technical-analysis/bear-market-takes-swipe-at-bulls-but-elf-stock-box-azn-cat-show-thick-hides/ | As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year? | Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-04 05:11:00 | https://www.fool.com/investing/2023/01/04/3-dividend-growth-stocks-to-buy-for-2023/ | Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road. | 3 Outstanding Dividend Growth Stocks to Buy for 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-01-03 10:23:00 | https://www.fool.com/investing/2023/01/03/beat-the-dow-jones-with-this-unstoppable-dividend/ | This drugmaker is accustomed to outperforming the broader market. | Beat the Dow Jones With This Unstoppable Dividend Stock | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-01-03 09:00:04 | https://www.investors.com/research/best-stocks-to-buy-now/ | Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist? | These Are 5 Of The Best Stocks To Buy And Watch Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2023-01-03 08:00:00 | https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301711230.html | NORTH CHICAGO, Ill. , Jan. 3, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 41st Annual J.P. | AbbVie to Present at the 41st Annual J.P. Morgan Healthcare Conference | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-01 08:29:55 | https://seekingalpha.com/article/4567258-2023-big-year-testosterone-abbvie-ani-best-positioned-to-benefit | Results from three major testosterone trials expected in 2023, including the largest testosterone cardiovascular safety/efficacy trials for men and women. AbbVie led Androgel 1.62% 5,246-participant cardiovascular safety trial is also measuring efficacy for dysthymia, clinical fractures, anemia, and progression from pr... | 2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To Benefit | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-31 08:15:00 | https://www.fool.com/investing/2022/12/31/3-dividend-stocks-to-buy-hand-over-fist-in-2023/ | Two of these three are members of dividend royalty. | 3 Dividend Stocks to Buy Hand Over Fist in 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-31 07:25:00 | https://www.fool.com/investing/2022/12/31/3-best-value-stocks-to-buy-before-2023/ | Now's the time for investors to think strategically about how -- and how much -- the investing landscape has changed in just the past few months. | 3 Best Value Stocks to Buy Before 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2022-12-30 18:00:21 | https://www.investors.com/news/best-stocks-2022-oils-stocks-solar-medical-lead-list-of-100-top-stocks-last-year/ | Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business Daily. | 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-30 10:32:22 | https://www.zacks.com/stock/news/2033935/abbvie-inc-abbv-is-a-trending-stock-facts-to-know-before-betting-on-it | Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. | AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-29 10:15:59 | https://seekingalpha.com/article/4566898-selecting-dividend-aristocrats-schd-methodology-initial-results | I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD. | Selecting Dividend Aristocrats Using SCHD's Methodology - Initial Results | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2022-12-29 08:05:55 | https://www.investors.com/research/ibd-stock-analysis/abbvie-gets-new-fda-approval-demand-among-best-mutual-funds/ | Boosted by demand among the best mutual funds and an FDA approval, AbbVie shows strength in ailing market. The post FDA Approval, Top Funds Lift Drugmaker In Ailing Market appeared first on Investor's Business Daily. | FDA Approval, Top Funds Lift Drugmaker In Ailing Market | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-29 05:13:00 | https://www.fool.com/investing/2022/12/29/high-yield-dividend-stocks-to-supercharge-your-pas/ | Here are three dividend-paying stocks that could help fuel your retirement dreams. | 3 High-Yield Dividend Stocks to Supercharge Your Passive Income Portfolio | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2022-12-28 13:28:17 | https://investorplace.com/2022/12/7-dividend-stock-predictions-for-2023/ | In this article, I'll give you my dividend stock predictions for 2023. Because let's be honest, most investors can't say goodbye to 2022 fast enough. | Our Predictions for the Top 7 Dividend Stocks for 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-27 16:32:09 | https://www.zacks.com/stock/news/2032730/3-dividend-kings-nicely-suited-for-income-investors | Dividend Aristocrats, companies that have increased their dividend payouts for at least 25 consecutive years, are popular targets among income investors. However, a step above is the elite Dividend Kings group. | 3 Dividend Kings Nicely Suited for Income Investors | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-24 09:20:00 | https://www.fool.com/investing/2022/12/24/2-healthcare-stocks-you-can-buy-and-hold-for-the-n/ | These companies are safe havens during tough times, with above-average dividends. | 2 Healthcare Stocks You Can Buy and Hold for the Next Decade | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-21 09:53:00 | https://www.fool.com/investing/2022/12/21/this-unstoppable-growth-stock-is-nearing-a-once-in/ | The risk of a stalled top line in 2023 means the potential for reward for those who can see beyond it. | This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-20 22:09:00 | https://seekingalpha.com/article/4565630-berts-november-dividend-income-summary | We save a high percentage of our income each month, to help fuel our dividend stock portfolio. We received $855.31 in November dividend income. This was an 11.93% increase compared to November 2021. | Bert's November Dividend Income Summary | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-20 05:47:00 | https://www.fool.com/investing/2022/12/20/duplicate2019-healthcare-article-template-that-you/ | These companies have histories of rapid payout increases and the means to continue them. | 2 Exceptional Dividend Growth Stocks to Buy Now | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-19 10:32:26 | https://www.zacks.com/stock/news/2030022/abbvie-inc-abbv-is-attracting-investor-attention-here-is-what-you-should-know | Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. | AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-19 09:02:20 | https://www.zacks.com/stock/news/2029915/abbvie-abbv-vraylar-gets-fda-nod-for-major-depressive-disorder | FDA approves AbbVie's (ABBV) Vraylar (cariprazine) for its fourth indication - the adjunctive treatment of patients with MDD. | AbbVie (ABBV) Vraylar Gets FDA Nod for Major Depressive Disorder | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2022-12-18 18:21:17 | https://investorplace.com/2022/12/the-7-hottest-biotech-stocks-to-own-in-2023-and-beyond/ | Some of the hottest biotech stocks are safe and recession-proof. After all, we can't stop people from aging – at least, not yet. | The 7 Hottest Biotech Stocks to Own in 2023 and Beyond | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-16 21:49:04 | https://www.zacks.com/stock/news/2029770/time-to-buy-eli-lilly-lly-and-abbvie-abbv-stock-for-2023 | AbbVie's valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lilly's growth could support its stock next year. | Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2022-12-16 14:12:26 | https://www.youtube.com/watch?v=2BKAgCSoeGE | The "Halftime Report" traders debate the biggest analyst calls of the day. | JPMorgan's bullish call on biopharma | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-16 05:52:00 | https://www.fool.com/investing/2022/12/16/why-pfizer-stock-is-riskier-than-abbvie/ | Pfizer has a lot more revenue at risk over the next several years than AbbVie does. | Why Pfizer Stock Is Riskier Than AbbVie | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-16 05:05:00 | https://www.fool.com/investing/2022/12/16/dividend-stocks-double-your-return-in-10-years/ | Both companies should hurdle their patent cliff concerns. | 2 Dividend Stocks That Could Double Your Return in 10 Years | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-11 17:00:00 | https://seekingalpha.com/article/4563740-my-2022-top-3-picks-year-end-report-vici-value-abbvie-profits-google-decision-time | 2022 will soon be in the history books and it's been quite a ride. Tech collapse, inflation, recession: the macro environment looks stressful, but this market definitely has its advantages. | My 2022 Top 3 Picks Year-End Report: VICI Value, AbbVie Profits, Google Decision Time | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-10 05:41:00 | https://www.fool.com/investing/2022/12/10/2-ultra-reliable-dividend-stocks-you-can-buy-now-a/ | Here are two stocks that investors can count on to deliver increasing dividend payments for many years to come. | 2 Ultra-Reliable Dividend Stocks You Can Buy Now and Hold Forever | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-08 09:53:00 | https://www.fool.com/investing/2022/12/08/2-forever-stocks-you-can-buy-and-forget-about/ | These stocks are both beating the market this year. | 2 Forever Stocks You Can Buy and Forget About | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2022-12-07 14:09:44 | https://www.youtube.com/watch?v=6CAmk0CYGu0 | Nancy Tengler, Laffer Tengler Investments CEO, joins 'The Exchange' to discuss how to position your portfolio in a potential economic slowdown. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNB... | Dividend payers are one of the safest ways to be exposed in the market, says Nancy Tengler | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-07 10:08:54 | https://seekingalpha.com/article/4562939-abbvie-wont-sell-pe-reaches-14x | I am a long-term bull on AbbVie. Its strong Q3 earnings pushed its prices to a near record high. | AbbVie: I Won't Sell Till P/E Reaches 14x | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-06 10:32:21 | https://www.zacks.com/stock/news/2025746/abbvie-inc-abbv-is-a-trending-stock-facts-to-know-before-betting-on-it | AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. | AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-06 05:10:00 | https://www.fool.com/investing/2022/12/06/is-abbvie-stock-a-buy-now/ | The pharmaceutical company prepared well as Humira approaches its patent cliff next year. | Is AbbVie Stock a Buy Now? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-05 18:48:10 | https://www.zacks.com/stock/news/2025517/relative-strength-found-within-these-3-medical-stocks | The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain. | Relative Strength Found Within These 3 Medical Stocks | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-05 05:57:00 | https://www.fool.com/investing/2022/12/05/is-abbvie-stock-a-smart-contrarian-pick-for-2023/ | The pharma giant's story won't be over with anticipated sales declines for its top-selling drug. | Is AbbVie Stock a Smart Contrarian Pick for 2023? | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-04 06:00:00 | https://www.fool.com/investing/2022/12/04/heres-how-to-prepare-your-portfolio-for-2023/ | Efforts now could result in gains next year and beyond. | Here's How to Prepare Your Portfolio for 2023 | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2022-12-03 07:31:00 | https://www.fool.com/investing/2022/12/03/3-stocks-to-buy-hand-over-fist-in-december/ | These stocks could be big winners. | 3 Stocks to Buy Hand Over Fist in December | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2022-12-02 15:01:17 | https://www.investors.com/stock-lists/ibd-50/top-stocks-in-multiple-industries-build-bases-as-market-gains-strength/ | An array of top stocks in a wide variety of industries are building cup bases as the stock market recovers. The post Top Stocks In Multiple Industries Build Bases As Market Gains Strength appeared first on Investor's Business Daily. | Top Stocks In Multiple Industries Build Bases As Market Gains Strength | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Stockmarketcom | 2022-12-02 12:19:06 | https://stockmarket.com/featured/stocks-to-invest-in-right-now-3-biotech-stocks-to-watch-2022-12-02 | Is now a good time to add these biotech stocks to your watchlsit? | Stocks To Invest In Right Now? 3 Biotech Stocks To Watch | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-01 13:46:06 | https://seekingalpha.com/article/4561798-abbvie-inc-abbv-management-presents-piper-sandler-34th-annual-healthcare-conference | AbbVie Inc. (NYSE:ABBV ) Piper Sandler 34th Annual Healthcare Conference Transcript December 1, 2022 9:30 AM ET Company Participants Rob Michael - Vice Chairman and President Jeff Stewart - Executive Vice President and CCO Tom Hudson - Chief Scientific Officer Scott Reents - Chief Financial Officer Conference Call Part... | AbbVie Inc. (ABBV) Management Presents at Piper Sandler 34th Annual Healthcare Conference (Transcript) | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GuruFocus | 2022-11-30 17:31:29 | https://www.gurufocus.com/news/1902238/gurus-prescribed-these-health-care-stocks-in-the-3rd-quarter | Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morning. | Gurus Prescribed These Health Care Stocks in the 3rd Quarter | ABBV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.